Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE: Safety Overview

Metric DAPTOMYCIN DARIFENACIN HYDROBROMIDE
Total FAERS Reports 9,032 193
Deaths Reported 1,137 65
Death Rate 12.6% 33.7%
Hospitalizations 4,371 43
Average Patient Age 60.6 yrs 74.5 yrs
% Female Patients 38.8% 80.5%
FDA Approval Date Apr 11, 2018 Dec 22, 2004
Manufacturer Hainan Poly Pharm., Co., Ltd. Cipla USA Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued